Nursing care
Immunosuppressants: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Immunosuppressants blunt the immune response to prevent organ rejection or control autoimmune disease, and the entire nursing plan centres on infection risk. Assess for infection before every dose, hold and escalate for fever rather than simply documenting it, and monitor trough levels, renal function and blood counts throughout therapy.
Why this drug and not another
Immunosuppressants are prescribed after solid organ transplant, in autoimmune disease that has failed other therapy, and sometimes in severe inflammatory conditions where the immune system is doing more harm than good. Cyclosporine and tacrolimus are calcineurin inhibitors, used most often post-transplant to prevent rejection; azathioprine, mycophenolate and corticosteroids are added for their own mechanisms so that no single drug carries the full immunosuppressive load at toxic doses.
The choice of agent depends on the organ transplanted, the patient's renal and hepatic function, and how the patient has tolerated other agents. Tacrolimus is more potent than cyclosporine milligram for milligram and has largely replaced it in kidney and liver transplant protocols, but cyclosporine still appears in some regimens and in autoimmune conditions such as severe rheumatoid arthritis. Know which drug your patient is on and why, because the monitoring differs.
Administration and timing
Give immunosuppressants at the same time every day, and do not let a patient miss or double a dose without contacting the prescriber; trough levels are drawn immediately before the next dose, so timing consistency is not optional. Cyclosporine and tacrolimus should be given consistently in relation to food, since fat content alters absorption, and a patient who has been taking a dose on an empty stomach should keep doing so unless told otherwise.
Do not switch between brand and generic formulations of cyclosporine or tacrolimus without prescriber input, as bioavailability differs enough between products to push levels out of range. Oral suspensions and capsules for the same drug are not automatically interchangeable either. If a dose is delayed by more than a few hours, check institutional policy and call the prescriber rather than guessing.
Monitoring parameters
Trough drug levels, drawn just before the next scheduled dose, are the backbone of monitoring for cyclosporine and tacrolimus, because the therapeutic window is narrow and toxicity overlaps with underdosing symptoms. Renal function is checked regularly since both drugs are nephrotoxic, and a rising creatinine needs to be reported rather than assumed to be transplant-related.
Complete blood count is monitored for the myelosuppressive agents such as azathioprine and mycophenolate, and liver function tests are tracked across the class. Blood pressure and glucose are checked routinely too, since calcineurin inhibitors and corticosteroids both raise both. But infection risk is the whole nursing plan here: a fever in an immunosuppressed patient is investigated, not observed, because sepsis can progress from subtle to critical in hours when the normal inflammatory response is suppressed.
Adverse effects to report
Report any temperature above the threshold set by the treating team immediately, along with new cough, dysuria, redness at a line site, or diarrhoea, since these patients may not mount a typical infective picture and a low-grade fever can be the only sign of something serious. Tremor, headache and paraesthesia can signal cyclosporine or tacrolimus neurotoxicity and warrant a level check.
Gum hyperplasia and hirsutism are recognised cyclosporine effects and are worth documenting even though they are not emergencies. New-onset hyperglycaemia, hypertension or a sharp rise in creatinine should go to the prescriber the same shift. Bruising or unusual bleeding with azathioprine or mycophenolate points to marrow suppression and needs a same-day full blood count.
Contraindications and cautions
Live vaccines are contraindicated for any patient on a therapeutic immunosuppressive dose, and this extends to household contacts who may be offered a live vaccine, which should prompt a conversation with the prescribing team about timing and precautions. Active, untreated infection is a relative contraindication to starting or continuing these drugs and needs to be flagged before the next dose is given.
Use grapefruit juice cautiously or avoid it with cyclosporine and tacrolimus, since it inhibits the CYP3A4 pathway that metabolises them and can push levels into the toxic range. Pregnancy status matters for mycophenolate specifically, which carries a well-documented teratogenic risk, and reliable contraception is part of the treatment conversation for anyone of childbearing potential.
Teaching points the exam tests
NCLEX-style questions on this class usually hinge on one idea: infection prevention is the priority intervention, above comfort measures or even some other safety concerns, because the consequence of missed infection is the most severe. Expect questions asking you to select the finding that requires immediate follow-up, and fever is almost always the correct answer over things like mild nausea or fatigue.
Teach patients to avoid crowds and people who are unwell, to practise meticulous hand hygiene, and to report fever, chills or any sign of infection without waiting to see if it resolves. Reinforce that they must never stop the drug abruptly without medical advice, since doing so risks organ rejection or disease flare, and that all other prescribers and dentists need to know they are immunosuppressed before any procedure.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Why is fever treated so seriously in a patient on immunosuppressants?
Because the drug is suppressing the immune response that would normally produce other signs of infection, fever can be the only warning sign present and may already indicate a significant infection. It is treated as an urgent finding requiring prompt assessment and often cultures, not something to monitor and reassess later.
What is the difference between cyclosporine and tacrolimus nursing care?
Both are calcineurin inhibitors needing trough level monitoring, consistent timing with food, and nephrotoxicity surveillance. Cyclosporine is more associated with gum hyperplasia and hirsutism, while tacrolimus is more potent and more strongly linked to neurotoxicity and hyperglycaemia, so the specific adverse effects to watch differ even though the monitoring structure is similar.
Can a patient on immunosuppressants receive a flu shot?
Inactivated vaccines, including the injectable flu vaccine, are generally considered safe, but live vaccines such as the nasal flu spray or MMR are contraindicated. Always confirm with the treating team before any vaccination, since immunosuppressive regimens and disease context vary.
What should a nurse do if a trough level comes back high?
Hold the next dose if instructed and notify the prescriber immediately, since a high trough level signals accumulating toxicity risk including nephrotoxicity and neurotoxicity. Do not adjust the dose independently; the prescriber will decide whether to reduce, hold, or re-check.
More on pharmacology
Guides on this